Clinical and serological features of systemic sclerosis in a Chinese cohort

Clinical Rheumatology

Volumn 32, Issue 5, 2013, Pages 617-621

  Wang, Jiucun ^a,f   Assassi, Shervin ^b   Guo, Gang ^c   Tu, Wenzhen ^d   Wu, Wenyu ^e,f   Yang, Li ^g   Xiao, Rong ^h   Zhao, Yongqiang ^c   Chu, Haiyan ^a   Liu, Jie ^a   Ma, Yanyun ^a   Kim, Sarah J ^b   Jin, Li ^a   Mayes, Maureen D ^b   Zou, Hejian ^e,f   Zhou, Xiaodong ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Yiling Hospital   (China)

^d Shanghai Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^e FUDAN UNIVERSITY   (China)

^f FUDAN UNIVERSITY   (China)

^g CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^h CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Anti centromere antibody; Anti topoisomerase antibody; Autoantibodies; Pulmonary fibrosis; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY; DNA DIRECTED RNA POLYMERASE III; DNA TOPOISOMERASE; RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN ANTIBODY;

ARTICLE; CAUCASIAN; CHINESE; CLINICAL CLASSIFICATION; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HOSPITAL; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; CHINA; COHORT STUDIES; DNA TOPOISOMERASES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; UNITED STATES;

EID: 84878742828     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-2145-7     Document Type: Article

References (15)

1. Bunn CC, Black CM (1999) Systemic sclerosis: an autoantibody mosaic. Clin Exp Immunol 117:207
2. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35:35-42
3. Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E et al (1996) Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 39:1362-1370
4. Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA (2012) A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum. doi: 10.1002/art.34482
5. Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK et al (2009) HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum 60:3807-3814
6. McNeilage LJ, Youngchaiyud U, Whittingham S (1989) Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 32:54-60
7. Low AH, Johnson SR, Lee P (2009) Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis. J Rheumatol 36:787-793
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
9. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205
10. Assassi S, Sharif R, Lasky RE, McNearney TA, Estrada-Y-Martin RM, Draeger H et al (2010) Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther 12:R166
11. Fritzler MJ, Ayer LM (1982) Anticentromere antibodies: clinical and biological significance. J Rheumatol 9:489-490
12. Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K et al (2008) The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 158:487-495
13. Meyer O, De Chaisemartin L, Nicaise-Roland P, Cabane J, Tubach F, Dieude P et al (2010) Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study. J Rheumatol 37:125-130
14. Bardoni A, Rossi P, Salvini R, Bobbio-Pallavicini F, Caporali R, Montecucco C (2003) Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. Clin Exp Rheumatol 21:301-306
15. Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EK, Bubb MR et al (2011) Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol 30:1333-1339